Guru Anand Bodhi delivers a science-backed showdown between Ozempic's GLP-1 receptor manipulation and intermittent fasting's metabolic reset. Discover which approach wins on weight loss, sustainability, and long-term health—or whether the real answer lies beyond choosing sides. For more content like this, visit QuietPlease.ai This content was created in partnership and with the help of Artificial Intelligence AI.